Announcements Trials
Browse Landscape

Status

Completed 60Unknown 34Recruiting 30Not yet recruiting 8Active not recruiting 7Withdrawn 4Terminated 4Enrolling by invitation 3

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 80Breast 44Thoracic 30Other hematologic neoplasm 25Genitourinary 25Lymphoid 20Head & Neck 16CNS 16Tumor-Agnostic 13Dermatologic 13Endocrine 12Other solid neoplasm 11Gynecologic 11Classical hematology 7Plasma cell 6Myeloid 4Sarcoma 3Other 3NET 3

Conditions

Neuroendocrine Tumors 3Prostatic Neoplasms 1Melanoma 1Disease Progression 1Carcinoma, Neuroendocrine 1Carcinoma 1Carcinoid Tumor 1Breast Neoplasms 1Adenocarcinoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × NET × Clear all
NCT00923026 2026-05-22

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
1,150 enrolled
DermatologicEndocrineNET

Adenocarcinoma, Carcinoma, Melanoma, Neuroendocrine Tumors

NCT05160480 2026-03-10

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

University of California, Davis

Enrolling by invitation
9 enrolled
BreastEndocrineGenitourinaryNET

Breast Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors

NCT02270567 2025-11-13

RegisterNET

Wren Laboratories LLC

Enrolling by invitation
400 enrolled
EndocrineNET

Carcinoid Tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡